Atlas Trials

Effect of Empagliflozin on NT-Pro Brain Natriuretic Peptide in Heart Failure Patients With Reduced Ejection Fraction

Clinical trial NCT05778084 · UNKNOWN

Trial details

NCT number
NCT05778084
Sponsor
Alexandria University
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Heart Failure With Reduced Ejection Fraction
Start date
2022-12-15
Primary completion
2024-06-15
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.